The current valuation score of Agenus Inc is 8.97, ranking 71 out of 386 in the Biotechnology & Medical Research industry. Its current P/E ratio is 2.97, which is 0.98% below the recent high of 3.00 and 47531.94% above the recent low of -1408.82.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.